Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

Two in-vitro and one in-vivo experimental studies have shown that ethyl 2-bromoisobutyrate induced reverse mutation in salmonella typhimurium and micronuclei in the polychromatic erythrocytes of the bone marrow of mice.

Short description of key information:
Ethyl 2-bromoisobutyrate has to be considered as mutagen since 3 experimental studies carried on the topic conclude in the presence of a risk on gene mutation

Endpoint Conclusion: Adverse effect observed (positive)

Justification for classification or non-classification

Ethyl 2-bromoisobutyrate has to be considered as Mutagen. The hazard statement Mutagen cat.1B and the sentence H340 "May cause genetic defects" are then required.